Interleukin 2 Receptor Antagonists [MoA] - N0000010279

Pharmacologic Class Information

Pharmacologic Code N0000010279
Pharmacologic Name Interleukin 2 Receptor Antagonists
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Interleukin 2 Receptor Antagonists

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Interleukin 2 Receptor Antagonists [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0078-0331Simulect Non-Proprietary Name: BasiliximabInjection, Powder, For SolutionIntravenousNovartis Pharmaceuticals CorporationACTIVE
0078-0393Simulect Non-Proprietary Name: BasiliximabInjection, Powder, For SolutionIntravenousNovartis Pharmaceuticals CorporationACTIVE